Welcome to HCV 2020!
We are excited to welcome you to Montreal, Canada for the 27th International Symposium on Hepatitis C Virus and Related Viruses which will be held at the Centre Mont-Royal from July 6-9, 2020.
The International Symposium on Hepatitis C Virus and Related Viruses has been a recurring annual conference since 1994. It has become the main forum for basic science investigators working on hepatitis C virus (HCV) and related viruses. Over the past 25 years, this conference has been instrumental in developing and advancing major discoveries in the HCV field including the understanding of the virus life cycle and development of in vitro replication systems and animal models that led to the development of direct acting antivirals (DAA) that have revolutionized HCV treatment. Key discoveries in understanding the immune response and pathogenesis of HCV presented at this meeting are now the basis for ongoing vaccine development and preclinical trials. Despite this progress, basic research on HCV remains at the forefront to drive HCV elimination efforts and reduce the morbidity and mortality of the disease. Research into vaccine development, HCV pathogenesis and liver cancer following DAA treatment, novel diagnostics and sequencing approaches to track the evolution and transmission of HCV in at-risk populations are only some of the key remaining research questions.
The HCV2020 meeting will focus on the main objective of HCV elimination by bringing together Basic and Clinical investigators to discuss the remaining challenges in the HCV field and novel approaches to tackle them towards this aim. The symposium will bring together keynote lectures from outstanding senior investigators and rising stars in virology, immunology and liver disease. In addition, high quality oral and poster presentations will be selected from submitted abstracts.
- Tools for HCV Elimination: Diagnostics, Sequencing and Beyond
- Innate Immunity/Virus-Host Interaction
- Virus Life Cycle 1 (Entry and Replication)
- Virus Life Cycle 2 (Translation and Assembly)
- Adaptive Immunity
- Global challenges to HCV Elimination
- Liver Inflammation, Viral Pathogenesis and Carcinogenesis
- Animal Models, Organoids and Replication Systems
- Antivirals, Challenges and New Frontiers
We look forward to welcoming you in Montreal, Quebec, Canada!
|Naglaa H. Shoukry, BPharm., PhD
Professor of Medicine,
Université de Montréal and CanHepC
|Jordan Feld, MPH, MDAssociate Professor of Medicine,
University of Toronto
|Daniel Lamarre, PhDProfessor, Department of Pathology,
Case Western Reserve, University,
Cleveland, OH, USA